Therefore, we transfected GM-CSF and G-CSF negative HT-29 cells with a GM-CSF complementary DNA (cDNA) expression plasmid or the empty vector and established stable cell lines for further experiments aiming at identifying the mechanisms of GM-CSF driven tumor progression. This evidence concerns the gene CSF2 and neoplasm.